ABL1 and acute lymphoblastic leukemia: Although most studies on Ph + ALL use RT-qPCR to evaluate for MRD, some data indicate that RQ-PCR examining heavy chain and T-cell receptor rearrangements may actually be superior, as BCR-ABL1 can sometimes be detected in non-ALL hematopoietic cells causing an increase in false positive results [18].